Bert Top

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

Jeffrey A. Kern, Robbert J.C. Slebos, Bert Top et al. · Journal of Clinical Investigation · 1994 · 181 citations · Full text

C-erbb-2 Expression, Pathology, Cancer Biology +16

The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.

Ulla‐Maija Koivisto, Hannu Turtola, Katriina Aalto‐Setälä et al. · Journal of Clinical Investigation · 1992 · 106 citations · Full text

Genetics, Genetic Epidemiology, Pathology +19

Diagnostic Value of Monitoring Human Cytomegalovirus Late pp67 mRNA Expression in Renal-Allograft Recipients by Nucleic Acid Sequence-Based Amplification

Marinus J. Blok, Valère J. Goossens, Sabina J. V. Vanherle et al. · Journal of Clinical Microbiology · 1998 · 95 citations · Full text

Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.

Sjoerd Rodenhuis, Lucie Boerrigter, Bert Top et al. · Journal of Clinical Oncology · 1997 · 94 citations

BCL-2 expression and mitochondrial activity in leukemic cells with different sensitivity to glucocorticoid-induced apoptosis

LA Smets, Joop van den Berg, D Acton et al. · Blood · 1994 · 84 citations · Full text